SCHEMBL20428345

SCHEMBL20428345

COC(=O)CCCC(=O)Nc1cc(N(C)c2cc(=O)oc3ccccc23)ccc1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.47
HTT P42858 2/20 0.47
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 5/20 0.46
NPSR1 Q6W5P4 3/20 0.46
LMNA P02545 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 2/20 0.44
TSHR P16473 1/20 0.44
HPGD P15428 6/20 0.42
MAPT P10636 6/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
GPR55 Q9Y2T6 1/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20428342 0.92 L3MBTL1 (0.51) SMN1; SMN2HTTALDH1A1KDM4ENPSR1
SCHEMBL20428330 0.92 ALDH1A1 (0.48) SMN1; SMN2HTTALDH1A1KDM4ENPSR1
SCHEMBL20428291 0.91 L3MBTL1 (0.53) SMN1; SMN2HTTALDH1A1KDM4ENPSR1
SCHEMBL20420732 0.91 L3MBTL1 (0.53) SMN1; SMN2HTTALDH1A1KDM4ENPSR1
SCHEMBL20428300 0.91 HTT (0.47) SMN1; SMN2HTTALDH1A1KDM4ENPSR1
SCHEMBL20420798 0.91 L3MBTL1 (0.53) SMN1; SMN2HTTALDH1A1KDM4ENPSR1
SCHEMBL20420792 0.90 HTT (0.48) SMN1; SMN2HTTALDH1A1KDM4ENPSR1
SCHEMBL20428309 0.90 ALDH1A1 (0.47) SMN1; SMN2HTTALDH1A1KDM4ENPSR1
SCHEMBL20428329 0.88 ALDH1A1 (0.44) SMN1; SMN2HTTALDH1A1KDM4ENPSR1
SCHEMBL28952542 0.88 ALDH1A1 (0.48) SMN1; SMN2ALDH1A1KDM4ENPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544134-B2 4-substituted coumarin derivatives and preparation methods and uses thereof GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD. (CN) 2020-01-28 US disclosed
EP-3354648-A1 4-SUBSTITUED COUMARIN DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF Guizhou Bailing Group Pharmaceutical Co., Ltd. (CN) 2018-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10544134-B2 4-substituted coumarin derivatives and preparation methods and uses thereof MAP4, TUBA3C, ABCC1 SMN1; SMN2 3998/4885HTT 4458/4885ALDH1A1 725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.